Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Future Pharmaceutical Industries (FPI) is a leading Egyptian pharmaceutical company dedicated to the development, manufacturing, and distribution of high-quality generic medicines. Established in 2004 and headquartered in Badr City, the company operates advanced manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards. FPI's extensive product portfolio covers a broad range of therapeutic areas, including cardiovascular, gastrointestinal, respiratory, and metabolic disorders. In addition to its proprietary branded generics, the company is a significant provider of contract manufacturing services (CMO) for both local and multinational pharmaceutical partners. FPI is committed to improving healthcare accessibility across the Middle East and Africa by providing affordable and effective therapeutic solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Future Pharmaceuticals Industries.